{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T19:49:19Z","timestamp":1771357759736,"version":"3.50.1"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T00:00:00Z","timestamp":1623974400000},"content-version":"vor","delay-in-days":71,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012095","name":"Scottish Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012095","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,4,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Bacterial co-infection is infrequently observed with SARS-CoV-2\/COVID-19 infection outside of critical care, however, antibiotics are commonly prescribed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To examine factors associated with antibiotic prescribing for suspected respiratory tract infection (RTI) and evaluate the nature and dynamics of prescribing in hospitalized patients with suspected and proven COVID-19 infection.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>An antibiotic point prevalence survey in hospitalized adult patients was conducted in designated COVID-19 clinical areas (including critical care) in 15 Scottish hospitals. Antibiotics prescribed for RTI and factors associated with prescribing were investigated.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of 820 surveyed patients, 272 (prevalence 33.3%) received antibiotics for suspected RTI on the survey day and 58.8% were SARS-CoV-2 positive. Antibiotics were empirical in 91.9% and amoxicillin (24.6%), doxycycline (20.5%) and co-amoxiclav (15%) were most frequently prescribed. Oral antibiotics were prescribed in 54.5% and duration was recorded in 76.7% on wards for a median of 5\u2009days. IV to oral switch occurred after a median of 2\u2009days. Prescribing for RTI was independently and positively associated with COPD\/chronic lung disease, purulent\/bloody sputum, abnormal chest X-ray, and CRP \u2265\u200a100\u2009mg\/L. Probable and definite hospital-acquired COVID-19 and diabetes were associated with a lower odds of receiving an antibiotic for RTI.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Antibiotic prescribing for suspected RTI was commonly observed and predominantly empirical in suspected or proven COVID-19. Initiatives to reinforce stewardship principles including clinical review, effective use of microbiological diagnostics and better understanding of the role of biomarkers are central to further limit unnecessary antibiotic therapy in COVID-19.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jacamr\/dlab078","type":"journal-article","created":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T19:13:50Z","timestamp":1620846830000},"source":"Crossref","is-referenced-by-count":11,"title":["Antibiotic prescribing for respiratory tract infection in patients with suspected and proven COVID-19: results from an antibiotic point prevalence survey in Scottish hospitals"],"prefix":"10.1093","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2509-0597","authenticated-orcid":false,"given":"R Andrew","family":"Seaton","sequence":"first","affiliation":[{"name":"Infectious Diseases Unit, Queen Elizabeth University Hospital, 1345 Govan Road, Glasgow, G51 4TF, UK"},{"name":"Scottish Antimicrobial Prescribing Group, Healthcare Improvement Scotland, Delta House, 48 West Nile Street, Glasgow, G1 2NP, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lesley","family":"Cooper","sequence":"additional","affiliation":[{"name":"Scottish Antimicrobial Prescribing Group, Healthcare Improvement Scotland, Delta House, 48 West Nile Street, Glasgow, G1 2NP, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheryl L","family":"Gibbons","sequence":"additional","affiliation":[{"name":"Public Health Scotland, NHS National Services Scotland, Meridian Court, 5 Cadogan Street, Glasgow, G2 6QE, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Malcolm","sequence":"additional","affiliation":[{"name":"ARHAI Scotland, NHS National Services Scotland, Meridian Court, 5 Cadogan Street, Glasgow, G2 6QE, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Choo-Kang","sequence":"additional","affiliation":[{"name":"Respiratory Medicine Unit, Glasgow Royal Infirmary, 84 Castle Street, Glasgow, G4 0SF, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Griffith","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Victoria Infirmary, Hayfield Road, Kirkcaldy, KY2 5AH, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Dundas","sequence":"additional","affiliation":[{"name":"Infection Unit, University Hospital Monklands, Monkscourt Avenue, Airdrie, ML6 OJS, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne","family":"Brittain","sequence":"additional","affiliation":[{"name":"Antimicrobial Management Team, Aberdeen Royal Infirmary, Foresterhill Health Campus, Foresterhill Road, Aberdeen, AB25 2ZN, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kayleigh","family":"Hamilton","sequence":"additional","affiliation":[{"name":"Antimicrobial Management Team, University Hospital Crosshouse, Kilmarnock Road, Crosshouse, Kilmarnock, KA2 0BE, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle","family":"Jeffreys","sequence":"additional","affiliation":[{"name":"Respiratory Medicine Unit, Raigmore Hospital, Old Perth Road, Inverness, IV2 3UJ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"McKinney","sequence":"additional","affiliation":[{"name":"Regional Infectious Diseases Unit, Western General Hospital, Crewe Road South, Edinburgh, EH4 2XU, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debbie","family":"Guthrie","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Ninewells Hospital, James Arrott Drive, Dundee, DD2 1SG, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1926-9491","authenticated-orcid":false,"given":"Jacqueline","family":"Sneddon","sequence":"additional","affiliation":[{"name":"Scottish Antimicrobial Prescribing Group, Healthcare Improvement Scotland, Delta House, 48 West Nile Street, Glasgow, G1 2NP, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,6,18]]},"reference":[{"key":"2021070810431579900_dlab078-B1","author":"Health Protection Scotland. National point prevalence survey of healthcare associated infection and antimicrobial prescribing","year":"2016"},{"key":"2021070810431579900_dlab078-B2","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"2021070810431579900_dlab078-B3","doi-asserted-by":"crossref","first-page":"m1985","DOI":"10.1136\/bmj.m1985","article-title":"Features of 20133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study","volume":"369","author":"Docherty","year":"2020","journal-title":"BMJ"},{"key":"2021070810431579900_dlab078-B4","author":"Scottish Antimicrobial Prescribing Group. SAPG response to COVID"},{"key":"2021070810431579900_dlab078-B5","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.jinf.2020.09.024","article-title":"Survey of antibiotic and antifungal prescribing in patients with suspected and confirmed COVID-19 in Scottish hospitals","volume":"81","author":"Seaton","year":"2020","journal-title":"J Infection"},{"key":"2021070810431579900_dlab078-B6","article-title":"Hospital onset COVID-19 cases in Scotland","author":"Public Health Scotland"},{"key":"2021070810431579900_dlab078-B7","doi-asserted-by":"crossref","DOI":"10.1136\/bmjspcare-2020-002558","article-title":"Antimicrobial use at the end of life: a scoping review","author":"Fairweather","year":"2020","journal-title":"BMJ Support Palliat Care"},{"key":"2021070810431579900_dlab078-B8","doi-asserted-by":"crossref","DOI":"10.1136\/bmjspcare-2020-002732","article-title":"Antibiotic use towards the end of life: development of good practice recommendations","author":"Seaton","year":"2021","journal-title":"BMJ Support Palliat Care"},{"key":"2021070810431579900_dlab078-B9","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.cmi.2020.07.016","article-title":"Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis","volume":"6","author":"Langford","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"2021070810431579900_dlab078-B10","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jinf.2020.05.046","article-title":"Co-infections in people with COVID-19: a systematic review and meta-analysis","volume":"81","author":"Lansbury","year":"2020","journal-title":"J Infect"},{"key":"2021070810431579900_dlab078-B11","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1080\/23744235.2020.1839672","article-title":"Few bacterial co-infections but frequent empiric antibiotic use in the early phase of hospitalized patients with COVID-19: results from a multi-centre retrospective cohort study in The Netherlands","volume":"53","author":"Karami","year":"2021","journal-title":"Infect Dis"},{"key":"2021070810431579900_dlab078-B12","article-title":"Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysis","author":"Malik","year":"2020","journal-title":"BMJ Evid Based Med"},{"key":"2021070810431579900_dlab078-B13","doi-asserted-by":"crossref","first-page":"m4357","DOI":"10.1136\/bmj.m4357","article-title":"How to optimise duration of antibiotic treatment in patients with sepsis?","volume":"371","author":"Hellyer","year":"2020","journal-title":"Brit Med J"},{"key":"2021070810431579900_dlab078-B14","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with COVID-19","volume":"384","author":"The RECOVERY Collaborative Group","year":"2021","journal-title":"New Engl J Med"},{"key":"2021070810431579900_dlab078-B15","doi-asserted-by":"crossref","first-page":"m3339","DOI":"10.1136\/bmj.m3339","article-title":"Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score","volume":"370","author":"Knight","year":"2020","journal-title":"BMJ"}],"container-title":["JAC-Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jacamr\/article-pdf\/3\/2\/dlab078\/38684934\/dlab078.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jacamr\/article-pdf\/3\/2\/dlab078\/38684934\/dlab078.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T19:23:19Z","timestamp":1625772199000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jacamr\/article\/doi\/10.1093\/jacamr\/dlab078\/6303600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,8]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4,8]]}},"URL":"https:\/\/doi.org\/10.1093\/jacamr\/dlab078","relation":{},"ISSN":["2632-1823"],"issn-type":[{"value":"2632-1823","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,6,1]]},"published":{"date-parts":[[2021,4,8]]},"article-number":"dlab078"}}